ReviewInternational journal of molecular sciences2022

SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease.

Luigi Mirarchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.